TR201110525A2 - Kemik hastalıklarının tedavisinde kullanılmak üzere suda çözünebilir farmasötik bileşimler. - Google Patents
Kemik hastalıklarının tedavisinde kullanılmak üzere suda çözünebilir farmasötik bileşimler.Info
- Publication number
- TR201110525A2 TR201110525A2 TR2011/10525A TR201110525A TR201110525A2 TR 201110525 A2 TR201110525 A2 TR 201110525A2 TR 2011/10525 A TR2011/10525 A TR 2011/10525A TR 201110525 A TR201110525 A TR 201110525A TR 201110525 A2 TR201110525 A2 TR 201110525A2
- Authority
- TR
- Turkey
- Prior art keywords
- treatment
- water
- pharmaceutical compositions
- bone diseases
- soluble pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Mevcut buluş hiperkalsemi, osteoporoz, tümör osteolizi, malin hiperkalsemi, metastatik kemik hastalığı, periprostatik kemik kaybı, Paget hastalığı gibi kemik hastalıklarının tedavisinde ve/ veya önlenmesinde kullanılmak üzere suda çözünebilir formülasyonlar ve bunların üretim yöntemleri ile ilgilidir.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2011/10525A TR201110525A2 (tr) | 2011-01-06 | 2011-10-24 | Kemik hastalıklarının tedavisinde kullanılmak üzere suda çözünebilir farmasötik bileşimler. |
PCT/TR2012/000007 WO2012093976A1 (en) | 2011-01-06 | 2012-01-06 | A composition comprising ibandronate at least 50 % of a filling agent and a sweetener |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2011/00151A TR201100151A2 (tr) | 2011-01-06 | 2011-01-06 | İbandronate formülasyonu. |
TR2011/10525A TR201110525A2 (tr) | 2011-01-06 | 2011-10-24 | Kemik hastalıklarının tedavisinde kullanılmak üzere suda çözünebilir farmasötik bileşimler. |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201110525A2 true TR201110525A2 (tr) | 2012-07-23 |
Family
ID=45722687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2011/10525A TR201110525A2 (tr) | 2011-01-06 | 2011-10-24 | Kemik hastalıklarının tedavisinde kullanılmak üzere suda çözünebilir farmasötik bileşimler. |
Country Status (2)
Country | Link |
---|---|
TR (1) | TR201110525A2 (tr) |
WO (1) | WO2012093976A1 (tr) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004275569B2 (en) * | 2003-09-29 | 2011-04-21 | Cipla Limited | Pharmaceutical formulation with improved stability |
WO2010117346A2 (en) * | 2009-04-10 | 2010-10-14 | Mahmut Bilgic | Stable pharmaceutical compositions with high bioavailibility |
-
2011
- 2011-10-24 TR TR2011/10525A patent/TR201110525A2/tr unknown
-
2012
- 2012-01-06 WO PCT/TR2012/000007 patent/WO2012093976A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2012093976A1 (en) | 2012-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013009701A3 (en) | Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders | |
SG10201907164SA (en) | Rna containing composition for treatment of tumor diseases | |
MX343687B (es) | Compuestos sulfonamida tricíclica y métodos para su fabricación y uso. | |
MX2016002544A (es) | Compuestos utiles como inmunomoduladores. | |
IN2012DN02736A (tr) | ||
MX2012013731A (es) | Vacunas que comprenden colesterol y cpg como moleculas portadoras-adyuvantes unicas. | |
MX2015006152A (es) | Compuestos de aminopirimidina como inhibidores de mutantes de egfr que contienen t7 9 0m. | |
GB201209613D0 (en) | New compounds | |
MX343688B (es) | Compuestos tricíclicos de sulfonamida y pirazolo y métodos para su fabricación y uso. | |
MX2013010343A (es) | Composicion y metodos para el transplante de microbiota de colon. | |
EP2576578A4 (en) | POLYMORPHES OF 2'-O-FUCOSYLLACTOSE AND MANUFACTURE THEREOF | |
MX344238B (es) | Compuestos de tetrazol y métodos para preparar y usar los mismos. | |
MX352324B (es) | Vacunas multivalentes de nanovehiculos sinteticos. | |
MX2014008706A (es) | Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos. | |
MX341395B (es) | Compuestos (lipopeptidos basados en cisteina) y composiciones como agonistas de tlr2 usados para el tratamiento de infecciones, inflamaciones, enfermedades respiratorias, etc. | |
MX2012010434A (es) | Compuestos y composiciones novedosas para atacar a las celulas madre del cancer. | |
MX2013001677A (es) | Formulaciones estables de linaclotida. | |
MX2014008705A (es) | Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos. | |
MY196771A (en) | Vesicles which include epidermal growth factor and compositions that contain same | |
MX357166B (es) | Anticuerpos que se unen a notum pectinacetilesterasa. | |
MX342119B (es) | 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
MX2015005732A (es) | Compuestos tricíclicos y métodos para hacer y utilizar los mismos. | |
CY1116158T1 (el) | Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3 | |
EP2528440A4 (en) | SUBSTITUTED NORINDEN ISOCHINOLINE, SYNTHESIS THEREOF AND METHOD OF USE THEREOF | |
MX2019012375A (es) | Formulaciones del inhibidor del antigeno-1 asociado a la funcion de linfocitos (lfa-1). |